Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Florian Forycki"'
Autor:
A. Michael Lincoff, Eric J. Topol, E. Magnus Ohman, Christopher Bode, Amadeo Betriu, Robert M. Califf, Amanda Stebbins, David J. Moliterno, William Bachinsky, Florian Forycki, Howard C. Herrmann, Jerry S Miklin
Publikováno v:
Journal of the American College of Cardiology. 36(5):1489-1496
OBJECTIVES We examined the utility of early percutaneous coronary intervention (PCI) in a trial that encouraged its use after thrombolysis and glycoprotein IIb/IIIa inhibition for acute myocardial infarction (MI). BACKGROUND Early PCI has shown no be
Autor:
Ralf Zahn, Florian Forycki, Gunther Berg, Gerhard Kratzsch, Andreas Graf, Wolfram Kamke, Ulrich Tebbe
Publikováno v:
American Heart Journal. 138:39-44
Background Thrombolytic agents are given in massive pulmonary embolism to dissolve or reduce the clot and normalize hemodynamics. Comparative clinical studies have shown that administration of a 2-hour infusion of alteplase is more effective than uro
Autor:
Robert L. Feldman, Richard W. Smalling, Gabriel B. Habib, Allen Seals, Florian Forycki, Peter Limbourg, Semi Sen, Stefan H. Hohnloser, John D. Kalbfleisch, Christoph Bode
Publikováno v:
Circulation. 91:2725-2732
Background Early restoration and maintenance of normal (TIMI 3) blood flow during acute myocardial infarction is critical for optimal preservation of left ventricular function and survival. Recombinant plasminogen activator (r-PA, reteplase) is a non
Autor:
T. Linderer, Florian Forycki, Joachim Wagner, Richard H. Arntz, Kathrin Kohl, Rolf Schröder, Marie-Luise Heineking, W. Wunderlich, Rudolf Henzgen
Publikováno v:
Journal of the American College of Cardiology. 22(5):1304-1310
Objectives. The purpose of this study was to compare the effects of very early (≤1.5 h after symptom onset) and later (>1.5 up to 4 h) thrombolytic therapy on infarct size, left ventricular function and early mortality in patients with acute myocar
Autor:
Rainer von Essen, A. Vogt, Klaus Haerten, Wolfgang Maeurer, Florian Forycki, Wolfgang Merx, Michael Riess, Ulrich Tebbe, Walter Niederer, Michael Roth, Peter Limbourg, Alexander Wirtzfeld, Karl-Ludwig Neuhaus
Publikováno v:
Journal of the American College of Cardiology. (5):885-891
Thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) and anisoylated plasminogen streptokinase activator (APSAC) in myocardial infarction has been proved to reduce mortality. A new front-loaded infusion regimen of 100 mg of rt-PA w